Schedule 13G ownership disclosure

VINCERX PHARMA INC

Common Stock, $0.0001 par value per share · CUSIP: 92731L304

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Prosight Management, LP

    Shares: 111,755.00 · Class: 4.99%

  • Prosight Fund, LP

    Shares: 9,662.00 · Class: 0.4%

  • Prosight Plus Fund, LP

    Shares: 30,006.00 · Class: 1.3%

  • Prosight Partners, LLC

    Shares: 111,755.00 · Class: 4.99%

  • W. Lawrence Hawkins

    Shares: 111,755.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-011863
Form type
SCHEDULE 13G/A
Filer
Prosight Management, LP
CIK
CIK 1617201
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub